Gu and co-authors found that TEP1 rs1713418 AG + AA genotypes were associated with 1.3-fold increased odds of prostate cancer in individuals younger than 69 years compared with the AA genotype (OR: 1.32, (95% CI: 1.02–1.70), p = 0.034). The gene discussed is TEP1; the disease is prostate carcinoma.